Cargando…
GA-Hecate antiviral properties on HCV whole cycle represent a new antiviral class and open the door for the development of broad spectrum antivirals
In recent years, synthetic peptides have been considered promising targets for drug development that possess low side-effects, are cost-effective and are susceptible to rational design. Hecate was initially described as a potent bacterial inhibitor and subsequently as an anticancer drug with functio...
Autores principales: | Batista, Mariana Nogueira, Sanches, Paulo Ricardo da Silva, Carneiro, Bruno Moreira, Braga, Ana Cláudia Silva, Campos, Guilherme Rodrigues Fernandes, Cilli, Eduardo Maffud, Rahal, Paula |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156508/ https://www.ncbi.nlm.nih.gov/pubmed/30254334 http://dx.doi.org/10.1038/s41598-018-32176-w |
Ejemplares similares
-
Antiviral Evaluation of New Synthetic Bioconjugates Based on GA-Hecate: A New Class of Antivirals Targeting Different Steps of Zika Virus Replication
por: da Silva Sanches, Paulo Ricardo, et al.
Publicado: (2023) -
Heat shock proteins HSPB8 and DNAJC5B have HCV antiviral activity
por: Braga, Ana Claudia Silva, et al.
Publicado: (2017) -
The Synthetic Peptide GA-Hecate and Its Analogs Inhibit Multiple Steps of the Chikungunya Virus Infection Cycle In Vitro
por: Ayusso, Gabriela Miranda, et al.
Publicado: (2023) -
Broad-Spectrum Antivirals and Antiviral Drug Combinations
por: Oksenych, Valentyn, et al.
Publicado: (2022) -
Broad-Spectrum Antivirals and Antiviral Combinations: An Editorial Update
por: Kainov, Denis, et al.
Publicado: (2022)